Ea. Tolskaya et al., FINAL CHECKPOINT IN THE DRUG-PROMOTED AND POLIOVIRUS-PROMOTED APOPTOSIS IS UNDER POSTTRANSLATIONAL CONTROL BY GROWTH-FACTORS, Journal of cellular biochemistry, 63(4), 1996, pp. 422-431
The treatment of HeLa subline (HeLa-B) cells with cycloheximide or Act
inomycin D resulted in a rapid (similar to 1.5 h and similar to 2.5 h,
respectively) development of morphological and biochemical signs of a
poptosis. The addition of fetal bovine serum to the cycloheximide-trea
ted or Actinomycin D-treated cells suppressed the apoptotic reaction,
as evidenced by the postponement of the DNA fragmentation for at least
9 and 5 h, respectively. A similar suppressive effect was observed up
on the serum addition to cells undergoing abortive infection with poli
ovirus, which died of apoptosis in the absence of the serum. The serum
appeared to exert its anti-apoptotic effect without any appreciable l
ag and even immediately blocked further progress of ongoing DNA fragme
ntation. The epidermal growth factor also suppressed, although less ef
ficiently and more transiently, the apoptotic reaction promoted by the
metabolic inhibitors. It is concluded that growth factors may affect,
without modulating either transcription or translation, the balance o
f pro-apoptotic and anti-apoptotic activities at a final checkpoint, j
ust preceding the irreversible effector step of apoptosis. (C) 1996 Wi
ley-Liss, Inc.